JPM 2023: Novocure Announces Trial Results; ResMed Expands Manufacturing; Abbott's IVD Bet Pays Off

Also: Thermo Fisher Projects Steady Growth, Labcorp Absorbs Acension; GE HealthCare Debuts As Standalone Company

J.P. Morgan Daily Notebook: Day 2
• Source: Shutterstock

More from Approvals

More from Policy & Regulation